POTASSIUM CHLORIDE INJECTION 40 mEq / 100 ML
POTASSIUM CHLORIDE : 40 mEq / 100 ML · DIN 02241679 · BAXTER CORPORATION
Health Canada status: MARKETED
What is POTASSIUM CHLORIDE INJECTION?
POTASSIUM CHLORIDE INJECTION 40 mEq / 100 ML contains POTASSIUM CHLORIDE : 40 mEq / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 02241679, held by BAXTER CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 10-Aug-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is POTASSIUM CHLORIDE INJECTION used for?
Potassium Chloride Injection is indicated for: treatment of potassium deficiency states where hypokalemia is severe. Severe hypokalemia is defined as a serum potassium concentration of less than 2.5 mEq/L; serum potassium less than 3.0 mEq/L with definite symptoms or ECG signs of hypokalemia; or serum potassium less than 3.2 mEq/L in the presence of metabolic acidosis and treatment with sodium bicarbonate or insulin is imminent. treatment of hypokalemia (K+ < 3.5 mEq/L) in postoperative cardiothoracic surgical patients, where a serum potassium concentration of 4.0 to 5.0 mEq/L is necessary to minimize ventricular arrhythmias. cautious treatment to abolish arrhythmias of cardiac glycoside toxicity precipitated by a loss of potassium. This regimen should not be used in patients with atrioventricular block. This highly concentrated, ready-to-use potassium chloride injection is intended for the rapid correction of hypokalemia and for potassium supplementation in fluid restricted patients who cannot accommodate additional volumes of fluid associated with potassium solutions of lower concentration.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02241679 |
|---|---|
| Brand name | POTASSIUM CHLORIDE INJECTION |
| Generic / active ingredient | POTASSIUM CHLORIDE : 40 mEq / 100 ML |
| Manufacturer | BAXTER CORPORATION |
| Strength | 40 mEq / 100 ML |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XA01 POTASSIUM CHLORIDE |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 10-Aug-2000 |
| Original market date | 2000-08-10 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
Is POTASSIUM CHLORIDE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code B05XA01 POTASSIUM CHLORIDE. 7 of 17 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE | 20 mEq / 10 ML | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00402206 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE | 200 mEq / 100 ML | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02480034 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP | 149 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00037869 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP | 149 MG | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | DIN 02485699 |
| POTASSIUM CHLORIDE INJECTION | 10 mEq / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 02241676 |
| POTASSIUM CHLORIDE INJECTION | 20 mEq / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 02241677 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP (2 MEQ/ML) | 2 mEq | SOLUTION | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 02231673 |
| POTASSIUM CHLORIDE INJ 149MG/ML USP | 149 MG | LIQUID | SABEX INC | CANCELLED POST MARKET | DIN 00398047 |
| POTASSIUM CHLORIDE INJ 149MG/ML USP | 149 MG | LIQUID | AYERST LABORATORIES | CANCELLED POST MARKET | DIN 00645842 |
| POTASSIUM CHLORIDE INJ 2MEQ/ML | 2 mEq | LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | CANCELLED POST MARKET | DIN 00243884 |
Who else supplies POTASSIUM CHLORIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. POTASSIUM CHLORIDE appears in 158 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.